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ABSTRACT
Background
Rates of diseases and injuries and the effects of their risk factors can have substantial
subnational heterogeneity, especially in middle-income countries like Mexico. Subnational
analysis of the burden of diseases, injuries, and risk factors can improve characterization of the
epidemiological transition and identify policy priorities.
Methods and Findings
We estimated deaths and loss of healthy life years (measured in disability-adjusted life years
[DALYs]) in 2004 from a comprehensive list of diseases and injuries, and 16 major risk factors, by
sex and age for Mexico and its states. Data sources included the vital statistics, national
censuses, health examination surveys, and published epidemiological studies. Mortality
statistics were adjusted for underreporting, misreporting of age at death, and for
misclassification and incomparability of cause-of-death assignment. Nationally, noncommuni-
cable diseases caused 75% of total deaths and 68% of total DALYs, with another 14% of deaths
and 18% of DALYs caused by undernutrition and communicable, maternal, and perinatal
diseases. The leading causes of death were ischemic heart disease, diabetes mellitus,
cerebrovascular disease, liver cirrhosis, and road traffic injuries. High body mass index, high
blood glucose, and alcohol use were the leading risk factors for disease burden, causing 5.1%,
5.0%, and 7.3% of total burden of disease, respectively. Mexico City had the lowest mortality
rates (4.2 per 1,000) and the Southern region the highest (5.0 per 1,000); under-five mortality in
the Southern region was nearly twice that of Mexico City. In the Southern region undernutrition
and communicable, maternal, and perinatal diseases caused 23% of DALYs; in Chiapas, they
caused 29% of DALYs. At the same time, the absolute rates of noncommunicable disease and
injury burdens were highest in the Southern region (105 DALYs per 1,000 population versus 97
nationally for noncommunicable diseases; 22 versus 19 for injuries).
Conclusions
Mexico is at an advanced stage in the epidemiologic transition, with the majority of the
disease and injury burden from noncommunicable diseases. A unique characteristic of the
epidemiological transition in Mexico is that overweight and obesity, high blood glucose, and
alcohol use are responsible for larger burden of disease than other noncommunicable disease
risks such as tobacco smoking. The Southern region is least advanced in the epidemiological
transition and suffers from the largest burden of ill health in all disease and injury groups.
The Editors’ Summary of this article follows the references.
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Knowledge about the relative contributions of diseases,
injuries, and their risk factors to the loss of healthy life is
needed for priority setting and for evaluation of health
programs. Most previous analyses of disease, injury, and risk
factor burden have been at the national or global scale [1–6].
In many countries, health policies and programs are
implemented and evaluated at the subnational level (e.g., at
the state level). Therefore, subnational analyses and evidence
are essential for debate, discourse, and cooperation among
different levels of government on health policies and
allocation of resources to health programs, as well as for
understanding disparities in health across regions. There
have been few subnational analyses of the burden of disease
[7]; more subnational analyses of mortality are available [8,9].
Mexico has experienced several decades of rapid epide-
miological and demographic change, making a combined
national and subnational analysis of the burden of diseases,
injuries, and their risk factors timely. Nationally, such an
analysis can reveal the extent, and the nutritional and
environmental determinants, of the epidemiological transi-
tion. In the epidemiological transition, the proﬁle of
population health evolves from one characterized by high
mortality and infectious diseases (typical of poor countries)
to one in which mortality rates are low and noncommuni-
cable diseases cause the majority of deaths (typical of wealthy
countries) [10–12]. A national analysis can contribute to the
very limited systematic analysis of speciﬁc disease and risk
factor drivers of the epidemiological transition. Extending
the analysis to the subnational level can reveal epidemio-
logical similarities, heterogeneities, and disparities, and their
implications for targeting policies and programs. In Mexico, a
subnational analysis can indicate whether regions are at
different stages of the epidemiological transition (as pre-
viously observed [13,14]), and whether the transition has the
same disease, injury, and risk factor drivers across regions.
Such evidence is especially relevant because states are an
important unit for resource allocation under Mexico’s recent
health system reform [15].
We estimated deaths and loss of healthy life years
(measured in disability-adjusted life years [DALYs]) from a
comprehensive list of diseases and injuries and from 16 risk
factors in Mexico and its states for 2004. The ﬁndings
enhance our understanding of the epidemiological transition
because we incorporate speciﬁc diseases, injuries, and risk
factors into the transition framework. In addition to the
utility of our ﬁndings for Mexico, this analysis can provide a
model, and illustrate data and information needs, for
epidemiological assessments in other countries.
Methods
We calculated mortality and burden of disease from a
comprehensive set of diseases and injuries and from selected
risk factors in 2004 using the methods and data sources
described below (Figure 1 provides a schematic overview of
the analysis steps). All analyses were performed at the state
level, by sex and age. For presentation, we grouped the 32
Mexican states into six geographic regions on the basis of per-
capita income, total mortality, and a composite deprivation
index (Figure S1, Table S1). The Northern and the Paciﬁc
Central regions are the most socially and economically
developed and have relatively close cultural and economic
links to the United States. The Southern region is the least
developed and has signiﬁcantly higher poverty and indige-
nous population than other regions. Mexico City is a highly
urbanized, wealthy region with excellent infrastructure but
with immigration from poor areas in the Central, Gulf, and
Southern regions. Regional and national results were ob-
tained by aggregating state-level results.
Mortality and Causes of Death
Total mortality rates. Although the great majority of deaths
are recordedin Mexico, mortality underreporting is suspected
in speciﬁc regions and among speciﬁc age groups. Misreport-
ing of age at death, migration, or incomplete census coverage
may also bias mortality rates calculated using vital registration
data. To address these potential sources of bias, we adjusted
total mortality by age, sex, and state. We applied the Trussell
version of the Brass method [16] to the 1990, 2000, and 2005
census data on children-ever-born and children-dead to
calculate the probability of dying before 5 y of age in each
state. We calculated adjusted adult death rates using the
GeneralGrowthBalancemethod[17,18].Wetheninterpolated
age-andsex-speciﬁcmortalityratesbetweenmortalitylevelsof
the ‘‘West family’’ of Coale-Demeny life-tables [19].
Causes of death. In Mexico, all recorded deaths are
medically certiﬁed and coded according to the International
Classiﬁcation of Disease (ICD) system (10th revision). The
medical information available at the time of death and
certiﬁcation practices vary by region, leading to incompara-
ble recorded cause of death data. We adjusted the observed
cause-of-death distribution for assignment to ill-deﬁned
codes and for incomparability of cause-of-death assignment
across states as follows (see Table S2 and Text S1 for details):
Figure 1. Steps of the Analysis
All calculations were carried out by age group, sex, and state. National
and regional estimates of deaths, DALYs, and attributable disease burden
were calculated as the sum of state estimates.
doi:10.1371/journal.pmed.0050125.g001
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and to cancers with unknown sites following the Global
Burden of Disease (GBD) study algorithms [20]. (ii) Cardio-
vascular deaths assigned to ill-deﬁned cardiovascular codes
versus ischemic heart disease were redistributed using
individual-level records and variables that affect compara-
bility of certiﬁcation [21]. (iii) Deaths assigned to diabetes
mellitus versus cardiovascular and other noncommunicable
and communicable diseases were also redistributed using
individual-level records and variables that affect compara-
bility of certiﬁcation [22]. (iv) We redistributed injury deaths
assigned to several ill-deﬁned codes for unintentional injuries
pro rata to road trafﬁc injuries, falls, drowning, and other
unintentional injuries. (v) Finally, 3,329 deaths (less than 1%
of all deaths) were assigned to codes for alcohol use disorders
(a neuropsychiatric condition) as the underlying cause of
death. Many of these deaths were assigned another disease
(e.g., an injury, ischemic heart disease, or cirrhosis of the
liver) as one of the multiple contributing causes of death. We
judged that when another disease was included as a
contributing cause of death, alcohol use was likely a more
distal contributor to death (i.e., a risk factor). Therefore, we
assigned these deaths to the corresponding associated cause.
After adjusting the cause-of-death distribution, we grouped
diseases into the exhaustive GBD list of 136 diseases.
Disease-speciﬁc death rates. We estimated disease-speciﬁc
death rates by applying the adjusted distribution of the causes
of death to the adjusted total mortality ﬁgures (Table S3).
Burden of Disease and Injury
Burden of disease was measured in DALYs. DALYs are the
sum of the years of life lost to premature death (YLL) and
years lived with disability (YLD). Following the GBD study [2],
we calculated DALYs using age weights and a discount rate of
3%; the effects of these two normative components of DALYs
are examined in detail elsewhere [23]. We calculated YLL
using age- and disease-speciﬁc deaths, and YLD using
estimates of incidence and duration of nonfatal diseases for
Mexico and for the low-mortality countries in the World
Health Organization Region of the Americas (AMR-B), and
disability weights for each disease from the GBD study [20].
The methods used to calculate DALYs for individual diseases
and injuries from these inputs are described in Table S4, Text
S2, and elsewhere [20].
Comparative Risk Assessment
We used the comparative risk assessment methods, de-
scribed in detail elsewhere [3,24], to estimate deaths and
DALYs attributable to 16 selected risk factors. In summary, to
calculate deaths and disease burden attributable to a risk
factor, we ﬁrst calculated the population attributable fraction
(PAF) for each disease affected by each risk factor. PAF
measures the proportional reduction in mortality or disease
burden that would be observed if risk factor exposure were
reduced to an alternative (counterfactual) distribution. Inputs
to the PAF calculation are (i) current distribution of exposure
to a risk factor, (ii) relative risks for each disease caused by the
risk factor, and (iii) a counterfactual distribution of exposure
to which current exposure is compared. We used a counter-
factual exposure distribution that results in the lowest
possible population risk, known as the theoretical-mini-
mum-risk exposure distribution (Table S5). Using this
counterfactual allows quantifying the effects of all levels of
nonoptimal exposure in a consistent and comparable manner
for all risk factors. When relative risks for death and incidence
were different, we calculated separate PAFs for mortality/YLL
and for YLD. Deaths, YLL, and YLD from each disease
attributable to each risk factor were calculated by multiplying
PAF by total mortality, YLL, or YLD from that disease. The
attributable deaths and DALYs were summed across all
diseases and injuries affected by each risk factor. We also
calculated PAFs for combined exposure to selected groups of
risk factors, using methods described in detail elsewhere [25].
We measured risk factor exposure using data from subna-
tionally representative health examination surveys, the na-
tional census, and Mexican epidemiological studies (Table
S5). For most risk factors, data on exposure came from the
National Health and Nutrition Survey 2006 (ENSANut),
which was administered to 94,710 individuals in 48,304
households and is representative at the state level [26]. This
sample size is larger than health examination surveys in most
developed countries, most of which are not representative at
the state level.
We primarily used relative risks from meta-analyses of
epidemiological studies carried out world-wide (Table S5).
Using meta-analyses reduces inﬂuence of bias and variability
that may be present in individual epidemiological studies,
especially the smaller studies. Cross-country epidemiological
studies have demonstrated that relative risks for most risk
factor effects are similar across populations [27], indicating
that combining and applying international studies to Mexico
is appropriate. However, we did not use relative risks from
international meta-analyses for the effects of (i) alcohol use on
injuries and (ii) unsafe sex on HIV/AIDS. For these risks and
disease outcomes, the proportional increase in risk caused by
exposure may be affected by local socio-demographic,
epidemiologic, and policy factors (e.g., drinking and driving
behaviors and law enforcement; the prevalence of HIV
infection among individuals engaging in risky sex behaviors).
For this reason, we used epidemiological studies from Mexico
to quantify the effects of alcohol use on injuries (Table S5). To
estimate the proportion of HIV/AIDS attributable to unsafe
sex, we used data on probable transmission route recorded in
the National HIV/AIDS Registry [28].
Results
Mortality, Causes of Death, and Burden of Diseases and
Injuries
After adjusting for under- and over-registration of deaths
relative to census counts, including corrections for age
misreporting and underreporting of deaths, the total number
of deaths over 5 y of age decreased by 2.7%; however, under-
ﬁve deaths increased 41% nationally and by a factor of two or
more in Chiapas, Guerrero, and Michoaca ´n. Substantially
larger underreporting of infant and child deaths than of adult
deaths is consistent with previous studies [29–31]; the excess
number of adult deaths relative to census counts may be
caused by inclusion of deaths of Mexicans living abroad in the
mortality data or by an undercount of the population in the
national census. The annual child mortality rate was 5.0 per
1,000 children; 83% of 15-y-old males survive to age 60,
compared to 91% of females. Estimated national life expect-
ancy was 72.3 y for men and 77.8 y for women. Male life
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Subnational Burden of Disease in Mexicoexpectancy ranged from 70.6 y (similar to that of Guatemala)
in the Southern region to 73.8 y in the Paciﬁc Central region
(similar to Chile). Female life expectancy ranged from 75.3 y
in the Paciﬁc Central region (similar to Ecuador) to 79.1 y in
the central region (like the Czech Republic and only 1 y lower
than female life expectancy in the US; Table S1).
Despite its status as a middle-income country, total
mortality in Mexico (and particularly in the Mexico City
Metropolitan Area [MCMA]) was more similar to mortality in
high-income countries than in other middle-income nations
(Figure 2). Within Mexico, mortality was highest in the
Southern region, where age-standardized death rates were
27% higher than in the MCMA. Under-ﬁve mortality varied
substantially more across regions than total mortality (Figure
3), with under-ﬁve mortality in the Southern region (7.0 per
1,000 children) more than twice that of the Paciﬁc Central
region (3.1 per 1,000). Under-ﬁve mortality in the Southern
region was higher than the average in all lower-middle
income countries, whereas in other regions it was similar to,
or lower than, the upper-middle income countries.
Nationally, 75% of total deaths were from noncommuni-
cable (group II) diseases. The leading causes of death were a
number of group II diseases, including ischemic heart disease,
diabetes, cerebrovascular disease, and cirrhosis of the liver, as
well as road trafﬁc injuries and lower respiratory infections
(Table 1). After adjustment for inconsistent cause of death
assignment, 9.7% of deaths were caused by diabetes, with
particularly high mortality in the MCMA and Paciﬁc Central
regions(4.9per10,000;alldiseaseratesareage-standardizedto
Mexico’s population in 2000; Figure 2). Liver cirrhosis mortal-
ity was high throughout Mexico, but there were variations
acrossregions,withmortalityintheSouthernandGulfregions
nearly twice the Northern region and the MCMA (3.7 and 3.2
per 10,000 MCMA versus 1.7 and 2.1 per 10,000). Cirrhosis
mortality among men was nearly four times that of women (4.0
per10,000versus1.1per10,000).AmongmalesintheSouthern
and Gulf regions (the most highly affected groups), liver
cirrhosis caused 11.9% and 11.2% of deaths, respectively.
Communicable, maternal, perinatal, and nutritional (group
I) diseases were the underlying cause of 14% of deaths
nationally. The death rate from group I diseases in the
Southern region (8.7 per 10,000) was nearly twice those in the
Paciﬁc Central region and the MCMA (5.1 and 5.2 per 10,000).
Regional disparities were even greater for pneumonia and
diarrhea mortality among children; under-ﬁve mortality from
these two diseases in the Paciﬁc Central region was 2.5 per
10,000, more similar to high-income countries (0.25 per
10,000) than other upper-middle-income countries (7.8 per
10,000); rates in the Southern region were 13.7 per 10,000, a
ﬁgure typical of lower-middle-income countries (Figure 3).
GroupIIdiseasesaccountedfor68%ofDALYsnationallyand
many noncommunicable diseases were among the leading
causes of disease burden (Table 1). At the same time, there
were more group I diseases and injuries (group III) among the
leading causes of disease burden than among deaths. This
occurred because group I diseases disproportionately affect
children, and injuries mainly affect young adults, both resulting
Figure 2. Age-Standardized Mortality Rates (A) and Burden of Disease Rates (B) for Mexico and Its Regions, Divided by Disease Category
For comparison, the figure also shows mortality rates for all high-income and low-and-middle-income countries [52]. All rates are standardized to the
2000 national population of Mexico. Regions used to present results are: Northern: Baja California, Baja California Sur, Coahuila, Chihuahua, Nuevo Leo ´n,
Sonora, Tamaulipas; Pacific Central: Aguascalientes, Colima, Jalisco; Central: Durango, Guanajuato, Michoaca ´n, Morelos, Nayarit, Quere ´taro, San Luis
Potosı ´, Sinaloa, Tlaxcala, Zacatecas, and parts of Mexico State not in the Mexico City region; Mexico City: Distrito Federal and parts of Mexico State in the
contiguous urban area; Gulf: Campeche, Quintana Roo, Tabasco, Veracruz, Yucata ´n; Southern: Chiapas, Guerrero, Hidalgo, Oaxaca, and Puebla (Table
S1). Key: Ca, cancers; Cir, liver cirrhosis; Com, communicable; CVD, cardiovascular; DM, diabetes; Inj, injuries; Mat, maternal, perinatal, and nutritional;
NCom, other noncommunicable; NP, neuropsychiatric.
doi:10.1371/journal.pmed.0050125.g002
Figure 3. National and Regional Under-Five Mortality Rates, Divided by
Disease Category
For comparison, the figure also shows the rates for all high-income,
upper- and lower-middle-income, and low-income countries [52]. Key:
Com, other communicable; Diar, diarrhea; Inj, injuries; NCom, other
noncommunicable; Perinatal, perinatal; Resp, respiratory infections.
doi:10.1371/journal.pmed.0050125.g003
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Subnational Burden of Disease in Mexicoin relatively large YLLs compared to noncommunicable
diseases.AmonggroupIIdiseases,alargeburdenwasassociated
with neuropsychiatric conditions, to which few deaths are
directly assigned. This occurred partly because these diseases
are most common among young and middle-aged adults, who
form a large proportion of Mexico’s population.
In every region and state, noncommunicable diseases
caused the majority of DALYs, ranging from 63% in the
Southern region to 72% in the MCMA and Paciﬁc Central
regions. Although the proportion of disease burden from
group II diseases was lowest in the Southern region, their
absolute effect, measured as DALYs per 1,000 population, was
highest there (104 per 1,000 versus 96–98 per 1,000 in other
regions; Figure 2). With the exception of liver cirrhosis, there
was little variability in group II DALY rates among the other
regions. Cirrhosis burden of disease showed the same
regional and sex patterns as cirrhosis mortality.
A comparison of the leading causes of disease burden by
region shows the regional disparities in maternal and child
diseases: in the Southern region, birth asphyxia and lower
respiratory infections were the ﬁrst and third leading causes
of disease burden, respectively, with about twice as many
DALYs per 1,000 population as the national average.
Uniquely, diarrhea was also one of the ten leading causes of
disease burden in Chiapas, the poorest state in Mexico.
The rate of road trafﬁc deaths was lowest in the MCMA, a
highly motorized region (2.9 per 100,000 versus 4.1 per
100,000 nationally), and was also low in a highly motorized,
wealthy state (Nuevo Leo ´n; 3.1 per 100,000). Despite their
high rates of motorization, road trafﬁc mortality may be low
in these areas due to several factors, including quality of
emergency care and lower pedestrian exposure to trafﬁc [32].
Among other states, the lowest rate of road trafﬁc deaths was
in Chiapas (1.8 per 100,000), likely due to fewer roads and
cars, and thus low exposure to vehicular trafﬁc. Homicide was
among the six leading causes of disease burden in every
region except the Gulf region. Homicide death rates were
generally higher along the Paciﬁc coast of Mexico (3.6–7.2 per
100,000 versus 2.1 per 100,000 nationally), and particularly in
Guerrero. These were followed by the MCMA and states in
the Northwest of Mexico.
Comparative Risk Assessment
Nationally, and in every state and region, risk factors for
noncommunicable diseases contributed the most to the
burden of disease (Figure 4, Table 1). Jointly, alcohol use,
Table 1. Leading Causes of Death and Disability in Mexico (2004), by Disease and Risk Factor
Category Leading
Causes
of Death
Percentage of Total Deaths Leading Causes of
Disease Burden
Percentage of Total DALYs
Both Sexes
(n ¼ 468,000)
Men
(n ¼ 264,000)
Women
(n ¼ 205,000)
Both Sexes
(n ¼ 14,560,000)
Men
(n ¼ 7,896,000)
Women
(n ¼ 6,664,000)
Disease Ischemic heart
disease
13.0 12.6 13.6 Unipolar depressive
disorders
6.2 4.2 8.6
Diabetes mellitus
a 9.7 7.9 12.1 Road traffic collisions 4.6 6.5 2.4
Cerebrovascular
disease
6.0 5.1 7.1 Birth asphyxia and
birth trauma
4.3 4.6 4.0
Cirrhosis of the liver 5.5 7.5 2.9 Diabetes mellitus 3.5 3.0 4.2
Road traffic
collisions
4.4 6.1 2.1 Ischemic heart
disease
3.1 3.6 2.6
Chronic obstructive
pulmonary disease
4.0 4.0 3.9 Cirrhosis of
the liver
3.0 4.4 0.0
Lower respiratory
infections
3.9 3.7 4.1 Violence
(homicide)
2.9 4.6 0.0
Hypertensive heart
disease
3.2 2.5 4.1 Asthma 2.4 2.3 2.5
Birth asphyxia and
birth trauma
3.0 3.2 2.8 Alcohol use
disorders
2.4 3.6 0.0
Nephritis and
nephrosis
2.6 2.5 2.8 Lower respiratory
infections
2.3 2.4 2.3
Risk
factor
b
High blood
glucose
14.1 11.6 17.3 Alcohol use
c 7.3 11.4 2.4
High BMI 12.2 9.9 15.1 High BMI 5.1 4.3 6.0
High blood
pressure
9.9 8.8 11.4 High blood glucose 5.0 4.5 5.6
Alcohol use
c 8.3 12.1 3.3 High blood pressure 2.4 2.4 2.3
Tobacco smoking 5.2 6.0 4.3 Unsafe sex 1.8 1.9 1.7
Low fruit and
vegetable intake
4.6 4.6 4.5 Low fruit and
vegetable intake
1.4 1.6 1.2
Physical inactivity 4.4 3.8 5.0 High cholesterol 1.2 1.3 1.1
High cholesterol 3.5 3.1 4.1 Physical inactivity 1.2 1.1 1.3
Urban air pollution 1.6 1.5 1.7 Childhood and
maternal underweight
1.1 1.1 1.1
Unsafe sex 1.0 1.5 0.4 Tobacco smoking 1.1 1.4 0.6
aThe adjustments to correct for coding incomparability across states (see Methods) shifted diabetes from the leading to second leading cause of death in Mexico.
bDeaths attributed to multiple risk factors may not be summed, as some deaths are caused by more than one exposure [25].
cSome of the female injuries attributed to alcohol are caused by alcohol use among men.
doi:10.1371/journal.pmed.0050125.t001
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Subnational Burden of Disease in Mexicohigh blood pressure, high body mass index (BMI), high
cholesterol, low fruit and vegetable intake, physical inactivity,
tobacco smoking, and high blood glucose accounted for an
estimated 36% of deaths and 16% of disease burden. Among
these risks, alcohol use, high blood glucose, and high BMI
were responsible for the largest disease burden (Table 1), in
aggregate as well as in young and middle-aged adults (15–60
y). Fasting blood glucose levels (age-standardized mean of 5.5
mmol/l for men and 5.6 mmol/l for women) and BMI (27.6 kg/
m
2 for men and 29.1 kg/m
2 for women) in Mexico were among
the highest observed worldwide [33,34]. The disease burden
attributable to alcohol use was largely due to its effects on
alcohol use disorders, injuries, and liver cirrhosis, all three of
which contributed approximately equally to total burden
caused by alcohol use.
Mortality and burden of disease caused by high blood
cholesterol and tobacco smoking were relatively low in
comparison to those associated with high BMI, blood glucose,
and blood pressure (Table 1). This was due to lower measured
exposure to these risks: mean blood cholesterol in the 2006
ENSANut, used for this analysis, was 4.4 mmol/l for men, 4.5
mmol/l for women, low by international standards and also
lower than was found in prior nationally representative
surveys in 1987–1988 and 2000 [35,36]. Using mean blood
cholesterol measured in 2000 [36] would double deaths
attributable to high blood cholesterol, and make this risk
factor the ﬁfth leading cause of death. The differences in
mean blood cholesterol measured in the various recent
national surveys should be investigated. Although smoking
prevalence in Mexico is similar to that of many high-income
countries, especially for men (36% for men and 13% for
women), nearly half of smokers do not smoke daily, and most
of the remainder smoke fewer than ﬁve cigarettes per day
[37]. Low smoking intensity can also be seen in consumption
ﬁgures: despite having a slightly higher prevalence of smoking
than the US, Mexican adults consumed an average of 712
cigarettes per year, compared to 2,081 in the US [38]. Our
method for quantifying exposure to tobacco smoking (Table
S5) accounts for this lower intensity in the estimated effects.
Regionally, the largest proportional effects of tobacco
smoking on mortality and burden of disease were in the
wealthiest regions, in particular the Northern region, where it
was responsible for 9% of deaths (Figure 4). In contrast,
mortality and burden of disease caused by alcohol use were
negatively correlated with economic development, and were
highest in the Southern region, followed by the Central
region. Regional patterns of deaths associated with alcohol
use were caused primarily by differences in liver cirrhosis
rates, and were less affected by the effects of alcohol use on
other disease and injury outcomes.
Nationally, the burden of disease attributable to risk
factors that affect child mortality, including child and
maternal underweight and micronutrient deﬁciencies, unsafe
water and sanitation, and indoor air pollution from solid
fuels, were relatively small. These risks together were
responsible for 2.3% of all deaths and 2.7% of disease
burden (10.1% of deaths and 8.9% of DALYs under 5 y of
age). There were however important regional patterns and
disparities in the proportional and absolute effects of these
risks: in the Northern region, where exposure to these risk
factors was low, together they were responsible for less than
2% of under-ﬁve deaths (Figure 5). It is likely that in this
region, medical interventions such as improved neonatal care
are needed to further reduce infant mortality rates to levels
observed in high-income countries. In contrast, the same risk
factors were together responsible for 16% of under-ﬁve
deaths in the Southern region. The Southern region also had
a higher under-ﬁve mortality rate, likely caused by risk factor
exposures and less access to case management. This created a
highly unequal regional gradient in the absolute effects of
these risks. The South-to-North ratio of rates of under-ﬁve
mortality attributable to risk factors in this study ranged from
3.3 for vitamin A deﬁciency, with a well-established national
supplementation program, to 18 for indoor air pollution
from solid fuels. Unlike in other states, in Chiapas the burden
of disease attributable to childhood and maternal under-
weight (4.9 DALYs per 1,000 population) was nearly as large
as that of high blood glucose and high BMI (5.1 and 5.0
DALYs per 1,000).
Discussion
In this paper, we used detailed, consistent, and comparable
data and analyses to establish the role of diseases, injuries,
and their risk factors in the loss of health in Mexico, and
identiﬁed patterns by age, sex, and region. This analysis
demonstrated that the national burden of disease in Mexico is
dominated by noncommunicable diseases and their risk
factors, consistent with the epidemiological and nutritional
transition framework [10–12,39]. Further, the analysis re-
vealed important disease and risk factor patterns that
distinguish Mexico from high-income countries at broadly
similar stages of the epidemiological transition: the liver
cirrhosis and diabetes mortality in Mexico were substantially
higher than in high-income countries, but those of other
noncommunicable diseases, such as cardiovascular diseases,
were comparable. Mirroring these disease patterns, the
highest mortality and burden of disease were caused by the
high blood glucose, high BMI, and alcohol use risk factors,
with lower burden of disease attributable to tobacco smoking,
which was primarily due to lower exposure to tobacco. This
ﬁnding of the highest mortality and disease burden shows the
need for further research on the role of genetic, dietary, and
other environmental and health system factors as determi-
nants of high blood glucose and high BMI in Mexico.
The availability of high quality vital registration and
household and health surveys in Mexico, much of which is
representative at the state level, permitted in-depth national
and subnational analysis. These subnational ﬁndings allowed
for identiﬁcation and quantiﬁcation of state and regional
priorities and health disparities, and their disease, injury, and
risk factor causes. Beyond its applications to priority setting
and program design and evaluation in Mexico, this analysis
indicates that collecting mortality, disease, and risk factor
data at the subnational level and at a moderately high
frequency allows for analyses like ours, which capture and
characterize major epidemiological patterns and their geo-
graphic distributions. However, Mexico is exceptional in
terms of availability of high-quality health and health
examination data among developing and even developed
countries. Even in Mexico, data on exposure to some risk
factors are available only at the regional or national level, and
there are few sources on incidence of nonfatal sequelae. A
balance between the utility and cost of subnational data may
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indicators, which are calibrated against direct measurement
for a subset of participants [40,41].
This study has several limitations. First, while we used high-
quality mortality and risk factor data, substantially less data
were available to estimate disease incidence and duration,
which are used to calculate the disability associated with
nonfatal outcomes (i.e., YLDs). This is a relatively common,
although not universal, phenomenon [20], because deaths are
routinely recoded as a part of countries’ vital registration, but
disease incidence or duration are rarely recorded directly.
These epidemiological parameters may be recorded in small,
nonrepresentative studies. As a result of these data limi-
tations, for most diseases we relied partially or entirely on
regional incidence rates from the GBD study, which
incorporated data sources from Mexico as well as other
countries, rather than relying exclusively on Mexican data.
Future research should compare the implications of using
multiple data sources from a larger geographic area with
disease modeling, versus using fewer local studies to calculate
disease incidences. Second, we analyzed only selected risks to
health in the comparative risk assessment. Hundreds of risk
exposures are potentially harmful to human health; consid-
ering an exhaustive set of exposures was out of the scope of
this analysis. Potentially important omitted risks for Mexico
include speciﬁc dietary factors. Estimating the population
effects of dietary risks is constrained by difﬁculties in
measuring exposure, both for absolute intake and composi-
tion [42]. Given the importance diseases associated with high
BMI and blood glucose, further analysis of dietary patterns
and risk factors should be a research priority in Mexico.
Third, data on fasting blood glucose was only available for a
nonrepresentative subset of the Mexican population, and
therefore we used regression analysis to predict fasting blood
glucose for the general population (Table S5). Our relatively
high estimates of fasting blood glucose are consistent with
ﬁndings in a nonrepresentative survey of rural Mexicans and
with the high diabetes death rates [43]. Finally, relative risks
for most risk factors were from large international meta-
analyses, complemented with Mexican sources (Table S5).
Relative risks, which quantify the proportional relationship
between exposure and outcome, have been shown to be
consistent across populations for most risk factors and
diseases [27]; yet further analyses of heterogeneity, especially
for relationships such as high BMI and diabetes or alcohol use
and liver cirrhosis would reduce the uncertainty of our
results. For injuries as a result of alcohol use, despite using
epidemiological evidence from Mexico, uncertainty remains
because this association may vary even among different parts
of the same country.
A prior analysis of burden of disease in Mexico for 1991
found that Mexico faced a triple burden of disease, with
injuries (violence and road trafﬁc injuries), infectious disease
(lower respiratory infections and diarrhea), and noncommu-
nicable diseases (cirrhosis of the liver) all among the leading
ﬁve causes of disease burden [1]. In our analysis, perinatal
Figure 5. Under-Five Mortality Attributable to Leading Risk Factors in Four Mexican Regions, Divided by Disease Category
Key: Comm, other communicable; Diar, diarrhea; Inj, injuries; NCom, other noncommunicable; Perinatal, perinatal; Resp, respiratory infections.
doi:10.1371/journal.pmed.0050125.g005
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Subnational Burden of Disease in Mexicoconditions continued to be a leading cause of DALYs. Lower
respiratory infections remained among the leading causes of
disease burden in 2004 but shifted from the sixth to the tenth
leading cause of DALYs. Noncommunicable diseases, partic-
ularly neuropsychiatric conditions, diabetes, and cardiovas-
cular diseases, made up the majority of the leading causes of
loss of healthy life. Injuries, particularly road trafﬁc injuries,
remained important causes of loss of healthy life, but both
their share of burden and their absolute rates have decreased
since 1991. While these analyses are not directly comparable
because of differences in methods, data sources, and disease
categories used, they do illustrate that the health challenges
that Mexico faces have transitioned toward predominantly
noncommunicable diseases.
Coupled with these national results, our analysis demon-
strated subnational patterns of diseases and risk factors, with
implications for health policies and programs and for health
equity. Subnational analyses showed a strong regional and sex
pattern of liver cirrhosis mortality, and of the burden of
disease attributable to alcohol use, with the highest burden in
the most marginalized areas (the Southern, Central, and Gulf
regions). The extremely high liver cirrhosis rates found in
some parts of the country cannot be explained by the
quantity of alcohol consumed (which is lower in Mexico than
in the US or most European nations) [44]; rather they may be
related instead to beverage type, pattern of consumption, or
quality of alcohol, as hypothesized in a number of studies
[45,46]. Ecologic analyses have found a strong correlation
between pulque (a traditional fermented alcoholic beverage)
and spirits consumption and liver cirrhosis rates in Mexico
[47,48]. Other possible factors may include past hepatitis
infection (though recent surveys have found moderate
seroprevalence of hepatitis B [49] and hepatitis C [50]) or
dietary and metabolic factors [51]; some cause-of-death
misclassiﬁcation cannot be ruled out. Of these factors, only
alcohol use explains the higher cirrhosis mortality among
men.
The national ﬁnding in which noncommunicable diseases
and their risks represent the largest share of disease burden
also masks the large proportional and absolute effects of risk
factors that affect under-ﬁve mortality in the Southern
region. The epidemiological transition, in terms of the
proportion of deaths caused by maternal and infectious
diseases, is least advanced in the Southern region, which is
still plagued by high under-ﬁve mortality rates and a
substantial number of preventable under-ﬁve deaths. At the
same time, the absolute rates of noncommunicable diseases
and injuries were highest in the Southern region. The large
absolute burden from all three disease groups, including a
younger age of death from many noncommunicable diseases,
demonstrates the overall worse health status in this region. A
similar pattern was observed in a subnational analysis of
mortality in South Africa, where under-ﬁve mortality rates
were negatively correlated with the level of development, but
age-standardized noncommunicable disease rates were sim-
ilar across all regions [8]. These ﬁndings highlight that the
increase in the proportion of deaths caused by noncommu-
nicable diseases during the epidemiological transition is a
result of a rapid decrease in communicable and maternal
causes of death and an aging population. In fact, total age-
speciﬁc noncommunicable mortality rates also fall during the
epidemiological transition. As the epidemiological transition
progresses nationally, high child mortality may remain in less
developed regions, as observed in our analysis in Mexico and
in South Africa [8]. Injuries and speciﬁc noncommunicable
causes of death may lag or even decouple from overall group
trends due to exposure to speciﬁc risk factors, as is the case
for diabetes and liver cirrhosis in Mexico. An analysis such as
ours can identify such speciﬁc details of epidemiological
change, and hence provide evidence on which risk factors
should be priorities for policy intervention.
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Subnational Burden of Disease in MexicoEditors’ Summary
Background. The impact that a particular disease has upon a population
is known as the ‘‘burden of disease.’’ This burden is estimated by
considering how many deaths the disease causes and how much it
disables those still living. The relative contributions of different diseases
and injuries to the loss of healthy life from death and disability vary
greatly among countries. Broadly speaking, in low-income countries
(such as many African countries), infectious diseases and undernutrition
are the major causes of ill health and death whereas in high-income
countries (for example, the United States), noncommunicable diseases
such as heart disease, diabetes, and stroke are more important. As poor
countries become richer, they experience a change in the pattern of
disease away from infectious diseases and malnutrition and toward
noncommunicable diseases. Health experts call this change the
‘‘epidemiological transition’’ (epidemiology is the study of the distribu-
tion and causes of diseases in populations). Governments need to know
as much as possible about which diseases have the greatest burden—
and about where the country is in the epidemiological transition—to
help them implement effective health policies. For example, there is no
point in setting up treatment centers for a specific infectious disease in a
country where the disease no longer occurs. Equally importantly,
governments need to know which lifestyle choices and other genetic
and environmental factors affect the chances of people in their country
developing specific diseases so that they can provide relevant educa-
tional and intervention programs.
Why Was This Study Done? Most analyses of the burden of disease
have been done at the national and global scale. However, in middle-
income countries, different regions of the country may be at different
stages of the epidemiological transition and may, therefore, have very
different patterns of disease. In this study, the researchers investigate
whether this is the case for Mexico, a middle-income country that has
developed rapidly over the past few decades. Mexico recently reformed
its health system to improve access to health care for the poor and
underserved. Under this new system, individual states play an important
role in allocating health-care resources (as they do in many other
countries) so it is very important to know how the burden of disease
varies in different states of the country.
What Did the Researchers Do and Find? The researchers estimated
deaths and loss of healthy life years caused by various diseases and
injuries for Mexico and its states using data from death registers,
censuses, health examination surveys, and epidemiological studies. Loss
of healthy life years was measured using a metric called ‘‘disability-
adjusted life years’’ (DALYs)—one DALY is equivalent to the loss of one
year of healthy life because of premature death or disability. They also
identified the major risk factors for these diseases and injuries across the
country. Nationally, noncommunicable diseases (particularly heart
disease, diabetes, stroke, and liver cirrhosis) caused 75% of deaths and
68% of DALYs. Undernutrition, infectious diseases, and problems
occurring in mothers and infants around the time of birth (maternal
and perinatal diseases) caused 14% of deaths and 18% of DALYs. The
leading risk factors for disease in Mexico were being overweight, having
high blood glucose, and alcohol use. When the researchers studied
different regions of the country, they found that Mexico City had the
lowest death rate whereas the relatively undeveloped Southern region of
Mexico had the highest, particularly among young children. In Chiapas,
the most southerly state of Mexico, undernutrition and infectious,
maternal, and perinatal diseases caused nearly a third of DALYs. In
addition to the highest infectious disease burden, the Southern region
also had the highest noncommunicable disease and injury burden per
head of population.
What Do These Findings Mean? These findings indicate that Mexico as
a nation is at an advanced stage of the epidemiological transition. In
other words, because of the improvement in its economic status, the
burden of disease caused by infectious diseases and undernutrition has
decreased, and noncommunicable diseases now cause the largest share
of the total burden of disease. However, the study also shows that the
poorest regions of the country, which have the highest overall burden of
disease, are lagging behind the richer regions in terms of their position in
the epidemiological transition. Thus different health priorities need to be
set in different regions of Mexico (and in other middle-income countries
where the burden of disease is also likely to vary with region). Finally, the
information provided by this study about the forces driving the
epidemiological transition in Mexico, such as the importance of obesity
and alcohol use, should help public-health officials decide how to
improve the overall health of the Mexican population.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050125.
  A related PLoS Medicine Perspective by Martin Tobias further discusses
this research
  The World Health Organization provides information on the Global
Burden of Disease Project including links to other burden of disease
resources. It also provides detailed information on various aspects of
health in Mexico (in several languages), and an explanation of DALYs
  Read a detailed article on the ‘‘epidemiological transition’’ by Abdel
Omran, who proposed this idea in 1971
  A large amount of Mexican data is available online for Spanish
speakers. Complete raw mortality statistics can be found on the
Mexican Ministry of Health’s Web site http://sinais.salud.gob.mx/sinais.
php. Also online is the complete report of the ENSANUT survey
(Encuesta Nacional de Salud y Nutricio ´n 2006) http://www.insp.mx/
ensanut/, which was one of the major data sources used to determine
risk factor exposure
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